Riskpilot← Back to searchSign inGet full accessMeliva Vårdcentral Aros AB
ABActiveOrg 5563823896Götavägen 4General medical practice activities · NACE 8621Est. 199022 employees
Revenue 2025
SEK 29,9M
+5% vs 2024
EBITDA margin
10.7%
+29% vs 2024
Equity ratio
16.2%
Financial strength
Net profit 2025
SEK -71K
+12% vs 2024
| Revenue | SEK 29,9M | +5% |
| EBITDA | SEK 3,2M | +29% |
| Net profit | SEK -71K | +12% |
| Total assets | SEK 9M | +14% |
| Equity | SEK 1,5M | -5% |
| Employees | 22 | — |
Legal name
Meliva Vårdcentral Aros AB
Org number
5563823896
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 februari 1990
Share capital
SEK 100 000
Employees
22 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Schmidt, Matti Artturi Soininen, Herkko Westerholm, Anders Peter Mikael
Company purpose
Bolaget skall bedriva friskvård, hälsovård och sjukvård samt därmed förenlig verksamhet.
Address
Götavägen 4
Phone
+4618696015
Email
ekonomi@meliva.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 31 297 | 35 496 | 36 122 | 28 375 | 29 895 |
| Staff expenses | — | — | −20 325 | — | — |
| EBITDA | 2 950 | −284 | −1 178 | 2 480 | 3 204 |
| Depreciation & amort. | −71 | −245 | −303 | −167 | −184 |
| EBIT | 2 879 | −529 | −1 481 | 2 313 | 3 020 |
| Net financials | 29 | −25 | 30 | 80 | 121 |
| Profit before tax | 107 | −553 | −23 | −81 | −71 |
| Tax | −25 | −5 | — | −0 | −0 |
| Net profit | 82 | −558 | −23 | −81 | −71 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 663 | 7 486 | 7 405 | 7 915 | 8 999 |
| Equity | 1 292 | 1 632 | 1 609 | 1 528 | 1 458 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 6 370 | 5 854 | 5 796 | 6 386 | 7 541 |
| Total debt | 6 370 | 5 854 | 5 796 | 6 386 | 7 541 |
EBITDA margin
10.7%
This company
15.8%
Market median
-32% vs market
20212025
Equity ratio
16.2%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
-4.9%
This company
18.4%
Market median
-127% vs market
20212025
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20212025
Asset turnover
3.32×
This company
1.12×
Market median
+196% vs market
20212025
Debt / equity
5.17×
This company
0.62×
Market median
-734% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JJ Chief Auditor | Chief Auditor | 2025 |
MA External Signatory | External Signatory | 2022 |
AP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
ME External Signatory | External Signatory | 2022 – 2023 |
LG Audit | Audit | 2020 – 2022 |
JO Chief Auditor | Chief Auditor | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (13) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEHILÄINEN OY
Meliva Vårdcentral Aros AB Board members of Meliva Vårdcentral Aros AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Joakim Holmquist | Chief Auditor | 0 companies |
| Matti Artturi Schmidt | External Signatory | 0 companies |
| Mats Erik Birger Brolin | External Signatory | 0 companies |
| Leif Gunnar Skarle | Audit | 0 companies |
| Anders Peter Mikael Westerholm | Chief Executive Officer | 0 companies |
| Jens Oscar Simon Bertling | Chief Auditor | 0 companies |
| Marek Jan Jerwanski | Board of Directors | 0 companies |
| Anders Ajgeldinger-Nordqvist | Board of Directors | 0 companies |
| Anssi Petteri Hartiala | Board of Directors | 0 companies |
| Oskari Eskola | Board of Directors | 0 companies |
| Dariusz Boczar | Deputy Board Member | 0 companies |
| Britt Ann-Charlotte Beckman | Board of Directors | 0 companies |
| Mauritz Erland Stintzing Olsson | Board of Directors | 0 companies |
| Sami Jukka Petteri Koski | Board of Directors | 0 companies |
| Lars Thomas Ingvald Franzén | Chairman | 0 companies |
| Nils Gustaf Sebastian Anders Brolin | Deputy Board Member | 0 companies |
| Peter Lars-Erik Daneryd | Board of Directors | 0 companies |
| Herkko Sampa Soininen | Chairman | 0 companies |
| Kaisla Elina Lahdensuo | Board of Directors | 0 companies |
| Markku Eero Antero Näreneva | Board of Directors | 0 companies |
| Claudia Mercedes Echeverria Zarate | Board of Directors | 0 companies |
| Agneta Ingegerd Franksson | Chairman | 0 companies |